The Confusion between Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis as a Cause of Exfoliative Dermatitis: A Case Report
Downloads
Background: Pustular psoriasis and Acute Generalized Exanthematous Pustulosis (AGEP) are grouped under pustular diseases, in which their clinical manifestations are similar. Those diseases can lead to exfoliative dermatitis. Purpose:To evaluate a specific histopathological examination in differentiating Pustular Psoriasis and AGEP. Case: A 55-year-old woman presented with sudden redness and diffused scaly skin with multiple pustules and also fever. She had taken Cefadroxil 2 days before the scales and pustules appeared. Leukocytosis and histopathological examination results from biopsy supported the diagnosis of AGEP. The patient was then hospitalized and received steroid therapy. Within the first week of tapering off, the scales disappeared but the pustules increased. After such clinical findings, the histopathological examination results were revisited and reassessed. Thus, we considered changing the diagnosis to Pustular Psoriasis, and the therapy was switched to Methotrexate. The patient had a better outcome, and the pustules slowly disappeared entirely. Discussion: It is often difficult to differentiate between the pustules in pustular psoriasis and AGEP unless by thorough history-taking and physical examinations. AGEP is characterized by a widespread of pustules with an acute febrile onset; while pustular psoriasis is an acute variant of psoriasis where pustules are spread over erythematous skin and accompanied by high fever and leukocytosis. Conclusion: Histopathological examination is the gold standard for the establishment of pustular psoriasis diagnosis. The histopathological characteristics of pustular psoriasis and AGEP are difficult to differentiate. Therefore, we need detailed history-taking and physical examination to establish the diagnosis.
Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw Hill; 2019. p. 457–62.
Rendon A, Schakel K. Psoriasis pathogenesis and
treatment. Int J Mol Sci 2019; 20(6): 1-28.
WHO. Global report on Psoriasis. Geneva: WHO; 2012.
Hyde K, Kivelevitch D, Mansouri B. Pustular psoriasis : pathophysiology and current treatment perspectives. Dove press journal 2016: 131–44.
Szatkowski J, Schwartz RA, Hon D, Edin F. Acute
generalized exanthematous pustulosis ( AGEP ): a review and update. J Am Acad Dermatol 2015; 73(5): 843–8.
Sousa AS De, Papaiordanou F, Tebcherani AJ. Acute generalized exanthematous pustulosis x Von Zumbusch' s pustular psoriasis : a diagnostic challenge in a psoriatic patient 2015; 90(4): 557–60.
Kardaun SH, Kuiper H, Fidler V, Jonkman MF. The histopathological spectrum of acute generalized exanthematous pustulosis ( AGEP ) and its differentiation from generalized pustular psoriasis. J CutanPathol 2010; 37(12): 1220–9.
Abbas M, Holfeld K, Desjardins D, Zimmer J. Exanthematous pustulosis. J Dermatol Case Rep 2014; 30(8): 42–5.
Heelan K, Sibbald C, Shear NH. Cutaneus Reactions to Drugs In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw Hill; 2019. p. 751-2.
Gabay C, Towne JE. Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions. J Leukoc Biol 2015; 97:645–52.
Navarini AA, Valeyrie-Allanore L, Setta-Kaffetzi N, Barker JN, Capon F, Creamer D, Roujeau JC, Sekula P, Simpson MA, Trembath RC, et al. Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis. J Investig Dermatol 2013; 133:1904–7.
Bissonnette R, Fuentes-Duculan J, Mashiko S, Li X, Bonifacio KM, Cueto I, Suarez-Farinas M, Maari C, Bolduc C, Nigen S, et al. Palmoplantar pustular psoriasis (PPPP) is characterized by activation of the IL-17A pathway. J Dermatol Sci 2017; 85:20–6.
Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis.J Eur Acad Dermatol Venereol 2017;31(2):205-212.
Choon SE, Lai NM, Mohammad NA, Nanu NM, Tey KE, Chew SF. Clinical profile, morbidity, and outcome of adult-onset generalized pustular psoriasis : analysis of 102 cases seen in a tertiary hospital in Johor, Malaysia. Int J Dermatol 2014;53(6):676-84.
Iizuka H, Takahashi H. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res 2003; 295(Suppl 1): 55–9.
Wilsmann-Theis D, Schnell LM, Ralser-Isselstein V, Bieber T, Schon MP, Huffmeier U, Mossner R. Successful treatment with interleukin-17a antagonists of generalized pustular psoriasis in patients without IL36RN mutations. J Dermatol 2018; 45:850–4.
Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007; 25(6):529-34.
Robinson A, Voorhees AS Van, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, et al. Treatment of pustular psoriasis : From the Medical Board of the National Psoriasis Foundation. J Am Dermatology 2012; 67(2): 279–88.
Copyright (c) 2021 Berkala Ilmu Kesehatan Kulit dan Kelamin
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.